We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Broad Effectiveness: Study With Aripiprazole

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00036361
First Posted: May 10, 2002
Last Update Posted: November 11, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Otsuka America Pharmaceutical
Information provided by:
Otsuka Pharmaceutical Development & Commercialization, Inc.
May 8, 2002
May 10, 2002
November 11, 2013
July 2002
January 2003   (Final data collection date for primary outcome measure)
Safety Assessments
Not Provided
Complete list of historical versions of study NCT00036361 on ClinicalTrials.gov Archive Site
Safety Assessments
Not Provided
Not Provided
Not Provided
 
Broad Effectiveness: Study With Aripiprazole
Broad Effectiveness: Study With Aripiprazole
The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders
Not Provided
Interventional
Phase 3
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Schizophrenia
  • Schizoaffective Disorder
Drug: Aripiprazole
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
444
January 2003
January 2003   (Final data collection date for primary outcome measure)
  • Patients with Schizophrenia or Schizoaffective Disorder
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00036361
CN138-087
Not Provided
Not Provided
Not Provided
Not Provided
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical
Not Provided
Otsuka Pharmaceutical Development & Commercialization, Inc.
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP